The ALARA+ Coalition has released a suite of resources to help hospital leadership and decisionmakers implement enhanced radiation and occupational safety guidelines for clinicians and staff working in fluoroscopy laboratories. The new toolkits provide practical steps to protect cath lab team members from both occupational radiation ex...
Experts recommend implementing safer technologies and modernizing radiation safety standards to reduce preventable radiation exposure and orthopedic injuries. The consensus statement emphasizes the need for mandatory action to prioritize protecting healthcare workers, ensuring a healthy workforce for patients' access to lifesaving care.
A recent study evaluated the safety and effectiveness of the J-Valve Transfemoral System in treating symptomatic severe aortic regurgitation. The study showed sustained valve performance, meaningful symptom improvement, and evidence of reverse left ventricular remodeling at one year.
Deaths from non-ischemic CS have risen sharply in the US, while ischemic CS deaths declined between 1999-2020. Researchers warn of a growing public health challenge that requires policy initiatives and targeted trials.
A novel detection algorithm using finger cuff technology detected moderate-to-severe aortic stenosis with a sensitivity of 90.5% and 100% in African American patients, showing excellent performance for screening purposes.
Seven original research studies on cardiometabolic therapies, structural heart disease, peripheral intervention, and shock care are published simultaneously by JSCAI at SCAI 2026. These findings highlight the intersection of cardiometabolic management and structural heart care, with implications for patient outcomes.
A multi-center retrospective cohort study examined how cangrelor is used in real-world clinical practice around the time of surgery following PCI. The study found that varying dosing patterns can affect outcomes, with higher infusion rates associated with increased bleeding events and lower infusion rates linked to higher major adverse...
New findings suggest that clopidogrel monotherapy is associated with a lower risk of net adverse clinical events compared to aspirin monotherapy, even in patients at high risk of bleeding. This benefit is more pronounced in patients with high bleeding risk and complex procedures.
A new study found that electronic provider notifications significantly increased aortic valve replacement rates and improved survival among older patients with severe symptomatic aortic stenosis. The DETECT-AS trial showed that clinicians who received automated email alerts with abnormal heart ultrasound results detected AS were more l...
A novel blood return system has been shown to significantly reduce blood loss during pulmonary embolism procedures, with a median reduction of 97%. The study found that the system improved procedural efficiency and maintained hemodynamic efficacy without added therapies or major complications.
A new study found that COVID-19 significantly worsens cardiovascular outcomes, leading to higher one-year mortality rates in patients with severe heart attacks. Patients who survived a heart attack and experienced COVID-19 had a 25% higher one-year mortality rate compared to those without COVID-19.
The MitraClip procedure has been shown to be safe and effective for patients with mitral annular calcification, improving symptoms and quality of life. Despite higher mortality rates, patients with MAC experienced significant reductions in mitral regurgitation and improvements in quality of life, indicating a promising treatment option.
Researchers found that elevated Lipoprotein(a) levels are associated with a higher risk of major adverse cardiovascular events, including stroke and death. Patients with high Lp(a) levels should work closely with their healthcare provider to aggressively lower LDL cholesterol and manage other cardiovascular risk factors.
The CARPOOL study demonstrates radial-to-peripheral access achieves comparable procedural success rates to traditional common femoral artery access for lower extremity peripheral artery disease revascularization. However, the R2P group had higher major adverse limb events at six months due to target vessel revascularization.
The STEMI-DTU trial analyzed secondary endpoints, finding that major bleeding and vascular complications were associated with increased mortality in the control group. The study provided insight into the importance of technique and bleeding complications in heart attack treatments.
Researchers found a significant increase in TAVR search volume and a decline in SAVR searches over the past decade, reflecting a shift towards minimally invasive therapies. The study also highlighted disparities in awareness across rural and low-volume treatment areas.
Tirzepatide significantly reduces cardiovascular risk in high-risk patients, including those undergoing percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR). The study found tirzepatide consistently reduced major adverse cardiovascular events and mortality across multiple time points.
Transcatheter arterialization of the deep veins (TADV) significantly improves quality of life in patients with severe CLTI, reducing concerns about poor circulation and daily activities. Six months post-procedure, patients showed a 50% reduction in circulation concerns, improved sleep patterns, and reduced foot wound symptoms.
A new transcatheter mitral valve replacement (TMVR) procedure has shown significant benefits for patients with severe mitral regurgitation, reducing symptoms and improving quality of life. The study found that the treatment sustained clinical improvements over one year, with no major complications.
Researchers found that patients with single-vessel runoff maintained excellent patency through three years, and could safely benefit from minimally invasive treatment. The study results showed no significant difference in outcomes for patients with one or more vessels running blood to the lower leg.
A new sub-study suggests that using a sirolimus-eluting balloon can reduce the number of stents needed, making it a safe and effective way to treat certain heart attacks or unstable chest pain. At one year, the rates of target vessel failure and cardiac death were low and similar between the two groups.
A registry analysis found that while men and women with acute myocardial infarction-related cardiogenic shock differ in treatment options, clinical decisions are driven by objective markers of illness severity rather than sex. The study suggests significant differences in how treatment options are discussed with patients and caregivers.
The CERAMICS registry found that most patients survived hospital discharge, with 71% overall survival and 60% of those in the most severe stage E shock. Early use of a small heart pump improves outcomes in patients experiencing cardiogenic shock after a heart attack and stenting procedure.
Alexandra J. Lansky, MD, MSCAI, has been reappointed to a second five-year term as Editor-in-Chief of JSCAI, the official peer-reviewed journal of SCAI. The journal has rapidly expanded its global reach and established itself as a trusted source for original research, clinical guidance, and educational content in interventional cardiol...
The Society for Cardiovascular Angiography & Interventions and Canadian Association of Interventional Cardiology will host a joint conference featuring the latest clinical data, procedural guidance, and advanced expertise. The event aims to empower clinicians with rigorous data, practical education, and leadership development.
Nine medical societies endorse 'ALARA+' safety framework to minimize radiation exposure and orthopedic strain in fluoroscopy labs, aiming to ensure safer environments, equipment, and care. The new standard aims to reduce occupational harms affecting healthcare staff, including chronic pain and spinal conditions.
The Congressional Peripheral Artery Disease (PAD) Caucus will focus on legislative priorities including timely diagnosis, evidence-based treatment, and innovative therapies. The event brings together lawmakers, medical experts, and patient advocates to address the critical gap in PAD management.
The Accelerating Kids’ Access to Care Act removes administrative barriers, enabling children with complex or congenital medical conditions to access out-of-state specialty care. This legislation ensures timely, coordinated care for children in need of lifesaving treatment from highly specialized pediatric interventional cardiologists.
The Society for Cardiovascular Angiography & Interventions has released an expert opinion on the use of wire-free angiography-derived physiology (ADP) in coronary artery disease assessment. ADP uses computational modeling or AI to analyze standard coronary angiographic images, offering a potentially more efficient and effective approac...
The Society for Cardiovascular Angiography and Interventions (SCAI) reviewed the 2025 Interventional Cardiology Fellowship Match results, noting that nearly all applicants successfully matched but 71 positions remained unfilled. SCAI attributes this to a lack of trainees in the pipeline, citing factors like radiation exposure and burno...
The Society for Cardiovascular Angiography and Interventions (SCAI) and Cardiovascular Research Technologies (CRT) announce a new collaboration to elevate the field of interventional cardiology through shared education programming, legislative activities, and future research initiatives. The partnership aims to improve patient outcomes...
The SCAI position statement highlights the advantages of intracardiac echocardiography (ICE) in improving safety, efficiency, and patient access for structural heart interventions. ICE offers real-time, high-resolution imaging without general anesthesia, streamlining procedures and reducing complications.
The Society for Cardiovascular Angiography & Interventions calls for Medicaid payment parity, fairer valuation of CHD procedures, and new compensation models to support care for children and adults with congenital heart disease. This policy statement aims to improve outcomes by addressing economic inequities in the healthcare system.
The SCAI Door to Lactate Clearance Cardiogenic Shock Initiative aims to improve outcomes in cardiogenic shock by using lactate clearance as a practical solution. Measuring lactate at diagnosis and every 2-3 hours can guide early management decisions.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement providing best-practice guidance for the treatment of patent ductus arteriosus (PDA) in premature infants using transcatheter occlusion. The guidance emphasizes patient selection, pre-procedural planning, and post-procedure follow-u...
The American Heart Association (AHA) and the American College of Cardiology (ACC) have published a new set of clinical practice guidelines for left atrial appendage occlusion (LAAO) to guide stroke prevention in non-valvular atrial fibrillation (NVAF) patients. The guidelines provide specific recommendations for clinicians, patients, a...
The Society for Cardiovascular Angiography and Interventions (SCAI) has published evidence-based clinical practice guidelines for the management of chronic venous disease. The guidelines provide patient-centered recommendations on therapeutic options, including compression therapy, wound care, and minimally invasive procedures. Key fin...
SCAI has announced its new leadership for 2025–26, with Dr. Srihari S. Naidu assuming the role of President during SCAI Scientific Sessions 2025. Dr. Naidu plans to prioritize practical, high-impact science, advocating for policies that protect and empower the workforce.
Dr. Samantha Espinosa has been selected for the WIN-CHIP Fellowship to advance her training in complex procedures and contribute to women's representation in interventional cardiology. The fellowship aims to provide comprehensive technical training while addressing systemic barriers.
The Society for Cardiovascular Angiography & Interventions (SCAI) has recognized the expertise of its top interventionalists, who demonstrate excellence in clinical care, innovation, publication, and teaching. The MSCAI designation is awarded to outstanding individuals who have made significant contributions to the field.
The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a program called Ready to Launch, which connects medical students and early-career residents with leaders in interventional cardiology. The program aims to provide exposure to real-world clinical scenarios and lasting professional relationships.
The Society for Cardiovascular Angiography & Interventions (SCAI) recognized 30 exceptional early-career interventionalists who demonstrate leadership, clinical excellence, and a commitment to teamwork and service. The award celebrates their embodiment of SCAI's core values and clear potential to shape the future of the profession.
The Society for Cardiovascular Angiography and Interventions recognized several individuals for their exceptional leadership, research, and contributions to advancing interventional cardiology. Dr. Dean Kereiakes received the Helping Hearts Lifetime Service Award for his outstanding service, while Dr. Alexandra Lansky was honored with ...
Researchers connected AI and wearables, showing a 33.1% decrease in heart failure patients and improved medication adherence. A triage algorithm also reduced unnecessary testing and improved care decisions by 30%.
A novel technique, BATMAN, prevents LVOT obstruction during TMVR with a success rate of 92.7% and shorter procedure times. The study's findings suggest BATMAN may be an alternative to traditional LAMPOON techniques, offering improved efficacy and safety for certain patients.
Early TAVR is associated with lower rates of serious cardiovascular events, including stroke and heart failure hospitalization, compared to clinical surveillance in younger patients with asymptomatic aortic stenosis. Patients aged 65-70 years derived the most benefits from early intervention, experiencing significant reductions in stro...
New technologies, including pVAD systems and aspiration-based thrombectomy systems, demonstrate reduced serious cardiovascular outcomes in high-risk patients. These innovations provide safer options for patients with complex PCI and improve functional outcomes.
Studies project a 40% increase in tobacco-related coronary heart disease deaths by 2030, with Black women and American Indian/Alaska Native groups disproportionately affected. Cannabis use disorder is also linked to increased risk of cardiogenic shock, acute myocardial infarction, and arrhythmias.
The FAVOR III China Trial showed that machine learning-based approach identify top 10 prognostic factors for predicting 2-year major adverse cardiovascular events (MACE) after Quantitative Flow Ratio (QFR)-guided Percutaneous Coronary Intervention (PCI). Patients with pre-random PCI strategy changed, Left Circumflex artery (LCX) lesion...
New data reveals women are 8% more likely to experience major complications after TAVI and 50% more likely after LAAO device placement. Black patients with chronic limb-threatening ischemia face a significantly higher combined rate of major amputation and death, yet are 10% less likely to see a vascular specialist.